Concepedia

Joshua Jacobs

JJ

Statistics

Publications

25

Citations

2.8K

H-Index

21

Active since

2010

Affiliations

Allergy, Asthma and Clinical Research Center(Current)

Goethe University Frankfurt

Institute for Asthma and Allergy

Penn State Milton S. Hershey Medical Center

University of California San Diego

Joshua Jacobs is an author at Allergy, Asthma and Clinical Research Center specializing in pharmacology, pharmacotherapy, and clinical pharmacology.

ORCID

Publications per year

2010–2024

25

Publications

25

Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema

Bruce L. Zuraw, Paula J. Busse, Martha V. White et al. · New England Journal of Medicine · 2010 · 404 citations · Full text

, , +8

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

, , +6

Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks

Aleena Banerji, Marc A. Riedl, Jonathan A. Bernstein et al. · JAMA · 2018 · 296 citations · Full text

, , +11

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

Hilary Longhurst, Marco Cicardi, Timothy Craig et al. · New England Journal of Medicine · 2017 · 234 citations · Full text

, , +13

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

, , +15

1–5 of 25